当前位置:首页 - 行情中心 - 沃华医药(002107) - 财务分析 - 现金流量表

沃华医药

(002107)

  

流通市值:41.03亿  总市值:41.44亿
流通股本:5.71亿   总股本:5.77亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金901,655,983.68689,523,102.51464,617,345.83234,098,257.98
  收到其他与经营活动有关的现金18,412,574.399,035,349.325,809,630.241,764,007.48
  经营活动现金流入小计920,068,558.07698,558,451.83470,426,976.07235,862,265.46
  购买商品、接受劳务支付的现金144,453,343.17104,260,984.1268,986,792.732,066,818.82
  支付给职工以及为职工支付的现金164,025,095.58123,980,413.7484,635,690.6245,065,188.91
  支付的各项税费111,891,470.1480,789,964.4555,146,634.9926,871,865.35
  支付其他与经营活动有关的现金371,173,033.18280,825,836.68186,366,426.0183,691,728.17
  经营活动现金流出小计791,542,942.07589,857,198.99395,135,544.32187,695,601.25
  经营活动产生的现金流量净额128,525,616108,701,252.8475,291,431.7548,166,664.21
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额14,653,57214,650,27214,650,27214,650,000
  处置子公司及其他营业单位收到的现金净额820,000820,000820,000-
  投资活动现金流入小计15,473,57215,470,27215,470,27214,650,000
  购建固定资产、无形资产和其他长期资产支付的现金864,503.16546,677.53447,942.5358,750
  投资活动现金流出小计864,503.16546,677.53447,942.5358,750
  投资活动产生的现金流量净额14,609,068.8414,923,594.4715,022,329.4714,591,250
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金90,825,15273,185,1523,920,0003,920,000
  其中:子公司支付给少数股东的股利、利润21,560,0003,920,0003,920,0003,920,000
  支付其他与筹资活动有关的现金1,147,932.68802,679.4519,985.83-
  筹资活动现金流出小计91,973,084.6873,987,831.44,439,985.833,920,000
  筹资活动产生的现金流量净额-91,973,084.68-73,987,831.4-4,439,985.83-3,920,000
五、现金及现金等价物净增加额51,161,600.1649,637,015.9185,873,775.3958,837,914.21
  加:期初现金及现金等价物余额342,876,205.9342,876,205.9342,876,205.9342,876,205.9
  期末现金及现金等价物余额394,037,806.06392,513,221.81428,749,981.29401,714,120.11
补充资料:
  净利润88,791,071.62-41,177,664.22-
  资产减值准备1,950,661.77-1,545,569.11-
  固定资产和投资性房地产折旧29,205,157.78-14,649,977.89-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧29,205,157.78-14,649,977.89-
  无形资产摊销1,368,526.28-697,544.13-
  固定资产报废损失170,469.99-43,277.14-
  财务费用62,306.1-36,330.2-
  投资损失-1,763,146.58--820,176.99-
  递延所得税205,752.52-421,730.96-
  其中:递延所得税资产减少679,115.63-657,056.9-
    递延所得税负债增加-473,363.11--235,325.94-
  存货的减少11,720,945.6-4,289,633.59-
  经营性应收项目的减少3,301,923.17--2,144,298.11-
  经营性应付项目的增加-4,306,270.2-19,016,219.89-
  现金的期末余额394,037,806.06-428,749,981.29-
  减:现金的期初余额342,876,205.9-342,876,205.9-
  现金及现金等价物的净增加额51,161,600.16-85,873,775.39-
公告日期2026-01-202025-10-182025-07-222025-04-26
审计意见(境内)标准无保留意见
TOP↑